Genevoyager owns the self-developed insect baculovirus
One-Bac 4.0 system independent patent group. One-Bac 4.0 system through
introduction of new strategy of AAV expression element regulation, combined
with key process optimization, achieves high yield, high activity, solid rate, and
single batch capacity up to 1E+18vg in the process of large-scale production of
AAV using insect system.
Genevoyager one-stop gene therapy CDMO service platform with professional and experienced QC and QA team can provide perfect quality testing services.
The routine quality release testing items and methods based on AAV are as follows.
US: 3675 Market Street, Suite 200, Philadelphia, PA19104 Tel: +1 (215) 205-6963 | +086 027-65023363
E-mail: hui.wang@genevoyager.com
China: No128, Guanggu 7th Rd, East Lake High-tech Development Zone, Wuhan, China Tel: 17720522078
E-mail: marketing@genevoyager.com